Table 1 Patient demographic and disease characteristics at baseline (patient-reported outcome population analysis set: part B)
From: Validation of the novel Eosinophilic Esophagitis Impact Questionnaire
Characteristic | Adolescents aged 12 to < 18 years (n = 79) | Adults aged ≥ 18 years (n = 160) | Overall PRO population analysis sample (N = 239) |
|---|---|---|---|
Age (years) | |||
Mean (SD) | 15.0 (1.62) | 34.7 (11.32) | 28.1 (13.14) |
Median | 15.0 | 35.0 | 24.0 |
Q1: Q3 | 14.0: 16.0 | 24.0: 41.5 | 16.0: 38.0 |
Min: max | 12: 17 | 18: 68 | 12: 68 |
Sex, n (%) | |||
Male | 57 (72.2%) | 95 (59.4%) | 152 (63.6%) |
Female | 22 (27.8%) | 65 (40.6%) | 87 (36.4%) |
Race, n (%) | |||
White | 64 (81.0%) | 152 (95.0%) | 216 (90.4%) |
Black or African American | 7 (8.9%) | 1 (0.6%) | 8 (3.3%) |
Asian | 2 (2.5%) | 3 (1.9%) | 5 (2.1%) |
Other | 6 (7.6%) | 1 (0.6%) | 7 (2.9%) |
Not reported | 0 | 3 (1.9%) | 3 (1.3%) |
Ethnicity, n (%) | |||
Not Hispanic or Latino | 76 (96.2%) | 149 (93.1%) | 225 (94.1%) |
Hispanic or Latino | 3 (3.8%) | 10 (6.3%) | 13 (5.4%) |
Unknown | 0 | 1 (0.6%) | 1 (0.4%) |
Atopic comorbidity, n (%) | |||
Allergic rhinitis | 57 (72.2%) | 96 (60.0%) | 153 (64.0%) |
Asthma | 33 (41.8%) | 29 (18.1%) | 107 (44.8%) |
Atopic dermatitis | 45 (57.0%) | 62 (38.8%) | 62 (25.9%) |